Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Poolbeg Pharma announces expansion of POLB 001 into oncology

By: News Direct
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

--News Direct--

Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO Jeremy Skillington speaks to Proactive's Thomas Warner after announcing that the company has submitted a patent application for the use of POLB 001 in a new oncological indication. Skillington explains the reasons for the strategic expansion and reveals more about his vision for the molecule in the long term.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/poolbeg-pharma-announces-expansion-of-polb-001-into-oncology-711615119

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  253.79
+3.77 (1.51%)
AAPL  311.23
+0.97 (0.31%)
AMD  523.20
-19.32 (-3.56%)
BAC  54.17
+1.77 (3.38%)
GOOG  369.27
+13.59 (3.82%)
META  627.57
+4.59 (0.74%)
MSFT  428.05
+0.71 (0.17%)
NVDA  218.66
+3.91 (1.82%)
ORCL  236.34
+6.01 (2.61%)
TSLA  418.45
-5.25 (-1.24%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.